Loomis Sayles & CO L P Charles River Laboratories International, Inc. Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $1.73 Million - $2.34 Million	-8,991 Reduced 15.52%	48,953 $9.88 Million
Q4 2022 Feb 10, 2023	SELL	$197.11 - $250.07 $246,584 - $312,837	-1,251 Reduced 2.11%	57,944 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $129,349 - $177,632	709 Added 1.21%	59,195 $11.7 Million
Q2 2022 Aug 05, 2022	BUY	$204.13 - $302.4 $5.89 Million - $8.72 Million	28,835 Added 97.25%	58,486 $12.5 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $8.92 Million - $12.6 Million	-34,911 Reduced 54.07%	29,651 $8.42 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $5.5 Million - $7.03 Million	-15,661 Reduced 19.52%	64,562 $24.3 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $14 Million - $17.3 Million	-37,702 Reduced 31.97%	80,223 $33.1 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $1.36 Million - $1.72 Million	4,629 Added 4.09%	117,925 $43.6 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $21,221 - $25,455	85 Added 0.08%	113,296 $32.8 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $5.97 Million - $6.79 Million	26,885 Added 31.14%	113,211 $28.3 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $5.6 Million - $7.22 Million	-31,903 Reduced 26.98%	86,326 $19.5 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $1.08 Million - $1.72 Million	9,068 Added 8.31%	118,229 $20.6 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $1.99 Million - $3.59 Million	20,155 Added 22.64%	109,161 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $947,265 - $1.15 Million	7,515 Added 9.22%	89,006 $13.6 Million
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $10.2 Million - $11.7 Million	81,491 New	81,491 $10.8 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $21,471 - $25,847	-174 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $628 - $880	-6 Reduced 3.33%	174 $25,000
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $2,522 - $3,293	-24 Reduced 11.76%	180 $20,000
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $14,125 - $16,952	126 Added 161.54%	204 $27,000
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $18,836 - $21,574	-184 Reduced 70.23%	78 $9,000
Q1 2018 May 11, 2018	SELL	$98.19 - $115.2 $687 - $806	-7 Reduced 2.6%	262 $28,000
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $4,318 - $5,077	43 Added 19.03%	269 $29,000
Q3 2017 Nov 14, 2017	SELL	$96.72 - $109.26 $4,449 - $5,025	-46 Reduced 16.91%	226 $24,000
Q2 2017 Aug 14, 2017	BUY	N/A	272	272 $28,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.15 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$956 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$703 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$400 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$364 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account